3.100
−22,50%
2026-10-16
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -17.5% | -5.1% | 1 / 3 | +14.7% | +5.38 pp | -0.51 pp | +136.3% | -4.17 | — | 34,7 | +14,7% | −7,4 | −17,5% | — | -1.62 | — |
| Pts | 0 | 0 | 4 | 4 | 12 | 4 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 3.100 (close price on 2026-10-16)EPS (TTM): −2.343,3
Financial charts
1.Revenue & growth
VND bn34,7Q3/26
1.Revenue & growth
VND bn34,7Q3/26
2.Profit & growth
VND bn-7,38Q3/26
3.Profit mix (Penman)
VND bn-23,3Q3/26
4.Margins & cost structure
%1.9%Q3/26
5.Returns & cash cycle
% · days-9.3%Q3/26
6.Earnings quality & cash
VND bn-4,18Q3/26
7.Asset structure
VND bn168Q3/26
8.Funding & debt health
VND bn · times168Q3/26
9.Revenue backlog
VND bn4,49Q3/26
10.Valuation
times · %-1,3×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-738Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26